Guidelines, polypharmacy, and drug-drug interactions in patients with multimorbidity

BMJ. 2015 Mar 11:350:h1059. doi: 10.1136/bmj.h1059.

Authors

Alessandra Marengoni¹, Graziano Onder²

Affiliations

¹ Department of Clinical and Experimental Science, University of Brescia, 25123 Brescia, Italy Geriatrics Steering Committee, Italian Agency of Medicine, 00187 Rome, Italy Alessandra.Marengoni@unibs.it.
² Geriatrics Steering Committee, Italian Agency of Medicine, 00187 Rome, Italy Department of Geriatrics, Centro Medicina dell'Invecchiamento, Università Cattolica del Sacro Cuore, 00168 Rome, Italy.

PMID: 25761379
DOI: 10.1136/bmj.h1059

No abstract available

Publication types

Editorial
Comment

MeSH terms

Antidepressive Agents*
Contraindications
Depressive Disorder / drug therapy*
Diabetes Mellitus, Type 2 / drug therapy*
Drug Interactions*
Heart Failure / drug therapy*
Humans
Hypoglycemic Agents*
Practice Guidelines as Topic*

Substances

Antidepressive Agents
Hypoglycemic Agents